Steven Cohen's TYRA Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 874,192 shares of Tyra Biosciences, Inc. (TYRA) worth $22.98 M, representing 0.03% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 5 quarters.
Based on 13F filings, Steven Cohen has maintained this position in TYRA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 592,160 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Tyra Biosciences (TYRA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tyra Biosciences (TYRA) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +592,160 | Add 209.96% | 874,192 | $26.29 |
| Q3 2025 | +57,332 | Add 25.51% | 282,032 | $13.99 |
| Q2 2025 | +175,100 | Add 353.02% | 224,700 | $9.57 |
| Q1 2025 | +36,817 | Add 288.02% | 49,600 | $9.30 |
| Q4 2024 | +12,783 | New Buy | 12,783 | $13.90 |
Steven Cohen's Tyra Biosciences Investment FAQs
Steven Cohen first purchased Tyra Biosciences, Inc. (TYRA) in Q4 2024, acquiring 12,783 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Tyra Biosciences, Inc. (TYRA) for 5 quarters since Q4 2024.
Steven Cohen's largest addition to Tyra Biosciences, Inc. (TYRA) was in Q4 2025, adding 874,192 shares worth $22.98 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 874,192 shares of Tyra Biosciences, Inc. (TYRA), valued at approximately $22.98 M.
As of the Q4 2025 filing, Tyra Biosciences, Inc. (TYRA) represents approximately 0.03% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Tyra Biosciences, Inc. (TYRA) was 874,192 shares, as reported at the end of Q4 2025.